UK markets closed

MGC Pharmaceuticals Limited (MXC.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
20.50-1.50 (-6.82%)
At close: 04:16PM GMT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
4,732
3,388
4,732
2,963
2,079
Cost of revenue
2,922
1,937
2,922
1,652
1,905
Gross profit
1,810
1,451
1,810
1,310
174.665
Operating expenses
Research development
1,608
1,993
-
-
-
Selling general and administrative
10,312
13,059
10,312
6,313
4,308
Total operating expenses
16,071
17,049
16,071
13,380
11,979
Operating income or loss
-14,261
-15,598
-14,261
-12,070
-11,805
Interest expense
210.142
257.403
210.142
369.135
135.582
Total other income/expenses net
-6,297
-5,276
-6,297
-3,005
-6,842
Income before tax
-20,768
-21,132
-20,768
-15,437
-18,770
Income tax expense
0
2.018
0
-27.278
0
Income from continuing operations
-20,768
-21,134
-20,768
-15,409
-18,770
Net income
-20,347
-20,824
-20,347
-15,870
-19,363
Net income available to common shareholders
-20,347
-20,824
-20,347
-15,870
-19,363
Basic EPS
-7.10
-
-7.90
-8.30
-14.00
Diluted EPS
-7.10
-
-7.90
-8.30
-14.00
Basic average shares
2,947
-
2,566
1,906
1,382
Diluted average shares
2,947
-
2,566
1,906
1,382